R is regaining attention in 2026, especially in statistics-heavy and research-focused data science work.Python still leads in ...

It may be niche, but it's a big niche in a data-driven world.

In oncology drug development, biomarker-driven studies are pivotal, enabling the selection of patient populations most likely to benefit from specific therapeutic interventions. These studies have ...